S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary

Bruker Stock Price, News & Analysis (NASDAQ:BRKR)

$68.80
+0.84 (+1.24%)
(As of 12/7/2023 ET)
Compare
Today's Range
$67.39
$69.83
50-Day Range
$54.91
$68.80
52-Week Range
$53.79
$84.84
Volume
1.40 million shs
Average Volume
819,288 shs
Market Capitalization
$9.52 billion
P/E Ratio
31.71
Dividend Yield
0.29%
Price Target
$82.00

Bruker MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
19.2% Upside
$82.00 Price Target
Short Interest
Bearish
4.41% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.48
Upright™ Environmental Score
News Sentiment
1.10mentions of Bruker in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.97%
From $2.51 to $2.71 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.57 out of 5 stars

Medical Sector

114th out of 960 stocks

Medical Devices Industry

2nd out of 24 stocks


BRKR stock logo

About Bruker Stock (NASDAQ:BRKR)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

BRKR Stock Price History

BRKR Stock News Headlines

Recent Reports Are A Wake-Up Call For Investors
As the demand for lithium, an essential element to the energy revolution, increases globally, researchers are projecting a supply deficit as early as 2025. This has sparked a worldwide "gold rush" to find and develop new sources of this critical metal. Savvy investors are paying attention as mining companies race to meet this critical deadline.
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Bruker: Q3 Earnings Snapshot
Bruker Reports Third Quarter 2023 Financial Results
Earnings Outlook For Bruker
Here's Why Investors Should Buy Bruker (BRKR) Stock Now
Bruker Completes Acquisition of PhenomeX
Bruker (BRKR) Advances Novel 4D-Proteomics Capabilities
Bruker Corp
See More Headlines
Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2023
Ex-Dividend for 12/15 Dividend
11/30/2023
Ex-Dividend for 12/15 Dividend
11/30/2023
Today
12/08/2023
Dividend Payable
12/15/2023
Dividend Payable
12/15/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/08/2024

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
Life Sciences Tools & Services
Sector
Medical
Current Symbol
NASDAQ:BRKR
CUSIP
11679410
Employees
8,525
Year Founded
1960

Price Target and Rating

Average Stock Price Target
$82.00
High Stock Price Target
$98.00
Low Stock Price Target
$65.00
Potential Upside/Downside
+19.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$296.60 million
Pretax Margin
15.06%

Debt

Sales & Book Value

Annual Sales
$2.82 billion
Cash Flow
$3.10 per share
Book Value
$7.65 per share

Miscellaneous

Free Float
99,379,000
Market Cap
$9.52 billion
Optionable
Optionable
Beta
1.16

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Dr. Frank H. Laukien Ph.D. (Age 63)
    Chairman, CEO & President
    Comp: $1.82M
  • Mr. Gerald N. HermanMr. Gerald N. Herman (Age 65)
    Executive VP & CFO
    Comp: $858.09k
  • Dr. Mark R. Munch Ph.D. (Age 61)
    Corporate Executive VP and President of Bruker Nano Group & Corporate
    Comp: $1.44M
  • Mr. Juergen Srega (Age 68)
    President of Bruker CALID Group & Bruker Daltonics Division
    Comp: $646.99k
  • Dr. Falko Busse Ph.D. (Age 56)
    President of Bruker BioSpin Group
    Comp: $763.34k
  • Mr. Justin Joseph Ward
    Senior Director of Investor Relations & Corporate Development
  • Mr. J. Brent Alldredge J.D. (Age 48)
    General Counsel & Secretary
  • Stacey Desrochers
    Treasurer & Director of Investor Relations
  • Dr. Burkhard Prause Ph.D. (Age 56)
    President and CEO of Bruker Energy & Supercon Technologies, Inc.
    Comp: $595.96k














BRKR Stock Analysis - Frequently Asked Questions

Should I buy or sell Bruker stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BRKR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View BRKR analyst ratings
or view top-rated stocks.

What is Bruker's stock price target for 2024?

3 equities research analysts have issued twelve-month target prices for Bruker's stock. Their BRKR share price targets range from $65.00 to $98.00. On average, they predict the company's share price to reach $82.00 in the next year. This suggests a possible upside of 19.2% from the stock's current price.
View analysts price targets for BRKR
or view top-rated stocks among Wall Street analysts.

How have BRKR shares performed in 2023?

Bruker's stock was trading at $68.35 at the beginning of 2023. Since then, BRKR shares have increased by 0.7% and is now trading at $68.80.
View the best growth stocks for 2023 here
.

When is Bruker's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our BRKR earnings forecast
.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) posted its earnings results on Thursday, November, 2nd. The medical research company reported $0.74 EPS for the quarter, topping analysts' consensus estimates of $0.63 by $0.11. The medical research company earned $742.80 million during the quarter, compared to the consensus estimate of $718.83 million. Bruker had a trailing twelve-month return on equity of 32.20% and a net margin of 11.32%.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Monday, November 20th. Shareholders of record on Friday, December 1st will be paid a dividend of $0.05 per share on Friday, December 15th. This represents a $0.20 annualized dividend and a yield of 0.29%. The ex-dividend date is Thursday, November 30th.
Read our dividend analysis for BRKR
.

Is Bruker a good dividend stock?

Bruker (NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.30%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 9.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BRKR will have a dividend payout ratio of 7.38% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BRKR.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY23 earnings guidance on Thursday, November, 2nd. The company provided EPS guidance of $2.48-2.53 for the period, compared to the consensus estimate of $2.57. The company issued revenue guidance of $2.88-2.91 billion, compared to the consensus revenue estimate of $2.88 billion.

What is Frank H. Laukien's approval rating as Bruker's CEO?

126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Who are Bruker's major shareholders?

Bruker's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (7.23%), Massachusetts Financial Services Co. MA (5.34%), RTW Investments LP (2.44%), Fuller & Thaler Asset Management Inc. (1.61%), Invesco Ltd. (1.41%) and Brown Advisory Inc. (1.06%). Insiders that own company stock include Cynthia M Friend, Frank H Laukien, Gerald N Herman, Marc A Kastner, Mark Munch and Richard A Packer.
View institutional ownership trends
.

How do I buy shares of Bruker?

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Bruker have any subsidiaries?
The following companies are subsidiares of Bruker: Accel Instruments, Advances Diagnostic Solutions Pty. Ltd., Agapetus GmbH, Alicona Corporation, Alicona GmbH, Alicona Imaging, Alicona Imaging GmbH, Alicona Korea Pcific Ltd., Alicona Manufacturing Inc., Alicona SARL, Alicona UK Limited, Alicona s.r.l., Anasys Instruments Corporation, Anasys Instruments GmbH, Arxspan, Biocentra AS., Bruker (Beijing) Scientific Technology Co. Ltd., Bruker (Malaysia) SDN BHD, Bruker AXS GmbH, Bruker AXS Handheld Inc., Bruker AXS LLC, Bruker AXS Ltd., Bruker Advanced Supercon GmbH, Bruker Austria GmbH, Bruker Belgium S.A./N.V., Bruker BioSciences Securities Corporation, Bruker BioSpin AG, Bruker BioSpin Corporation, Bruker BioSpin GmbH, Bruker BioSpin K.K., Bruker BioSpin MRI GmbH, Bruker Business Support Center sp. z o.o, Bruker Daltonics GmbH, Bruker Daltonics Ltd., Bruker Daltonics Pty. Ltd., Bruker Daltonics S.r.l., Bruker Daltonik GmbH, Bruker Detection Corporation, Bruker EAS GmbH, Bruker Energy & Supercon Technologies Inc. , Bruker Espanola S.A., Bruker Finance B.V., Bruker France S.AS., Bruker HTS GmbH, Bruker India Scientific PVT Ltd., Bruker Invest AG, Bruker Italia S.r.l., Bruker JV Israel Ltd., Bruker JV UK Ltd., Bruker Korea Co. Ltd., Bruker Ltd., Bruker Mexicana S.A. de C.V., Bruker MicroCT N.V., Bruker Nano GmbH, Bruker Nano Inc., Bruker Nederland B.V., Bruker Nordic AB, Bruker OST LLC, Bruker Optics GmbH, Bruker Optics Inc. , Bruker Optik GmbH, Bruker PTY Ltd., Bruker Physik GmbH, Bruker Polska Sp. Z o.o., Bruker Portugal Unipessoal LDA, Bruker Scientific Instruments Hong Kong Co. Ltd., Bruker Scientific Israel Ltd., Bruker Scientific LLC, Bruker Singapore Pte. Ltd., Bruker South Africa (Pty) Ltd., Bruker Taiwan Co. Ltd., Bruker Turkey Teknolojik Sistemler Ticaret Ltd. Sirketi, Bruker UK Ltd., Bruker do Brasil Ltda., Bruker s.r.o., Hain LifeScience E.A. Ltd., Hain LifeScience GmbH, Hain LifeScience Solutions (Pty) Ltd., Hain LifeScience Spain S.L., Hain LifeScience UK Ltd., Hain LifeSciences S.A. Pty Ltd., Hydrostatic Extrusions Ltd., Hysitron, InCoaTec GmbH, InVivo Biotech Services GmbH, InVivo Biotech Svs GmbH, JPK Instruments Limited, JPK Instruments USA. Inc., JPK In­stru­ments, JUWE Laborgeraete, Jordan Valley Semiconductors, Keymaster Technologies, Luxendo, Luxendo GmbH, MAC Science, Merlin Diagnostika GmbH, Mestrelab Research S.L., Michrom Bioresources, Oncovision - Innovative Medical Imaging, PMOD Technologies, Prairie Technologies, Princeton Gamma-Tech Instruments Inc, Quantron, RI Research Instruments GmbH, Roentec AG, S.I.S. Surface Imaging Systems, SAS Biocentric, SCiLS GmbH, SkyScan, Socabim, VACUUMSCHMELZE GmbH & Co. KG, Vutara LLC, XGLabs S.r.l., and Yingsheng Technology.
Read More
This page (NASDAQ:BRKR) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -